0001736112-18-000001.txt : 20180413 0001736112-18-000001.hdr.sgml : 20180413 20180413172419 ACCESSION NUMBER: 0001736112-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20180413 DATE AS OF CHANGE: 20180413 EFFECTIVENESS DATE: 20180413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cote Fund for Orphan Drugs, LP CENTRAL INDEX KEY: 0001736112 IRS NUMBER: 824308706 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310197 FILM NUMBER: 18755082 BUSINESS ADDRESS: STREET 1: 3529 TILDEN STREET NW CITY: WASHINGTON STATE: DC ZIP: 20008 BUSINESS PHONE: 202-738-6335 MAIL ADDRESS: STREET 1: 3529 TILDEN STREET NW CITY: WASHINGTON STATE: DC ZIP: 20008 D 1 primary_doc.xml X0708 D LIVE 0001736112 Cote Fund for Orphan Drugs, LP 3529 TILDEN STREET NW WASHINGTON DC DISTRICT OF COLUMBIA 20008 202-738-6336 DELAWARE None None Limited Partnership true 2018 Timothy R Cote 3529 Tilden Street NW Washington DC DISTRICT OF COLUMBIA 20008 Executive Officer Pooled Investment Fund Hedge Fund false No Aggregate Net Asset Value 06b 3C 3C.1 false true true true true false 100000 Indefinite 0 Indefinite false 0 0 0 0 false Cote Fund for Orphan Drugs, LP Timothy R Cote Timothy R Cote Manager 2018-04-13